1. Home
  2. IQV vs RYAAY Comparison

IQV vs RYAAY Comparison

Compare IQV & RYAAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IQV
  • RYAAY
  • Stock Information
  • Founded
  • IQV 1982
  • RYAAY 1985
  • Country
  • IQV United States
  • RYAAY Ireland
  • Employees
  • IQV N/A
  • RYAAY N/A
  • Industry
  • IQV Biotechnology: Commercial Physical & Biological Resarch
  • RYAAY Air Freight/Delivery Services
  • Sector
  • IQV Health Care
  • RYAAY Consumer Discretionary
  • Exchange
  • IQV Nasdaq
  • RYAAY Nasdaq
  • Market Cap
  • IQV 37.2B
  • RYAAY 31.1B
  • IPO Year
  • IQV 2013
  • RYAAY 1997
  • Fundamental
  • Price
  • IQV $216.46
  • RYAAY $62.48
  • Analyst Decision
  • IQV Strong Buy
  • RYAAY Strong Buy
  • Analyst Count
  • IQV 20
  • RYAAY 1
  • Target Price
  • IQV $242.10
  • RYAAY $76.00
  • AVG Volume (30 Days)
  • IQV 1.7M
  • RYAAY 693.8K
  • Earning Date
  • IQV 10-28-2025
  • RYAAY 11-03-2025
  • Dividend Yield
  • IQV N/A
  • RYAAY 1.32%
  • EPS Growth
  • IQV N/A
  • RYAAY 34.93
  • EPS
  • IQV 7.30
  • RYAAY 2.23
  • Revenue
  • IQV $15,904,000,000.00
  • RYAAY $17,216,676,454.00
  • Revenue This Year
  • IQV $6.01
  • RYAAY $9.99
  • Revenue Next Year
  • IQV $4.87
  • RYAAY $5.21
  • P/E Ratio
  • IQV $29.64
  • RYAAY $13.14
  • Revenue Growth
  • IQV 3.85
  • RYAAY 9.23
  • 52 Week Low
  • IQV $134.65
  • RYAAY $38.52
  • 52 Week High
  • IQV $225.91
  • RYAAY $67.18
  • Technical
  • Relative Strength Index (RSI)
  • IQV 63.90
  • RYAAY 59.85
  • Support Level
  • IQV $209.46
  • RYAAY $60.68
  • Resistance Level
  • IQV $222.59
  • RYAAY $62.26
  • Average True Range (ATR)
  • IQV 5.99
  • RYAAY 0.98
  • MACD
  • IQV -0.12
  • RYAAY 0.07
  • Stochastic Oscillator
  • IQV 65.80
  • RYAAY 94.21

About IQV IQVIA Holdings Inc.

Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.

About RYAAY Ryanair Holdings plc

Ryanair is Europe's largest low-cost airline, known for its extensive network and highly efficient business model. Operating over 3,600 flights daily across 240-plus destinations in 40 countries, Ryanair has built its success on offering affordable air travel while maintaining tight control over costs. The airline primarily uses Boeing 737 aircraft, including the newer 737 8-200 "Gamechanger" variant, which simplifies operations and reduces expenses. Ryanair focuses on high passenger volume, ancillary revenue, and operational efficiency, ensuring its position as a leading airline in Europe.

Share on Social Networks: